Rights Issue Open in August 2026: Track all RE on NSE & BSE

Rights Issues allow existing shareholders to purchase additional shares of a company, usually at a discounted price, in proportion to their current holdings. This page provides a comprehensive view of upcoming and ongoing Rights Issues in India. As an investor, you can track record dates, subscription windows, Rights Entitlement (RE) trading periods, issue prices, ratios, issue sizes, and other important details in one place.

Whether you're checking your eligibility or deciding whether to subscribe, sell your REs, or buy additional REs from the market, this tracker can help you stay informed and avoid missing important deadlines.

When a rights issue is announced, eligible shareholders receive Rights Entitlements (REs) in their demat accounts. These are temporary securities that give investors the right - but not the obligation - to apply for additional shares under the rights issue.

REs can also be bought and sold on the stock exchange during the permitted trading window. Here is the list of **REs trading in August 2026**:

What are Rights Entitlements (REs)?

A Rights Entitlement (RE) is a short-term instrument issued to eligible shareholders when a company launches a rights issue.

Here’s what this means for investors:

• Credited to your demat account: Eligible shareholders receive REs in their demat accounts based on the rights issue entitlement.
• Represents eligibility: REs indicate the number of additional shares a shareholder is entitled to apply for at the rights issue price.
• Tradable on exchanges: REs can generally be bought or sold on the stock exchange during a limited trading window.
• Temporary in nature: REs have a limited life. If they are neither exercised nor sold within the prescribed timelines, they may lapse and become worthless.

In simple terms, REs give investors flexibility—they can participate in the rights issue, sell their entitlement during the permitted trading period, or choose not to act.

What Can You Do With Your REs?

If REs are credited to your demat account, you generally have three options:

Apply for the Rights Shares

Use your REs to apply for additional shares at the rights issue price announced by the company.

For example, eligible Sunrest Lifescience shareholders can apply for **1 additional share for every 1 share held on the record date, at an issue price of ₹35 per share.

Sell the REs on the Exchange

If you do not want to invest additional money in the company, you may sell your REs on the stock exchange during the permitted RE trading period.

For Sunrest Lifescience, the **last date for RE trading/renunciation is August 28, 2026**.

Take No Action

If you neither apply for the rights shares nor sell/renounce your REs within the applicable deadlines, the REs may lapse and cease to have any value.

Rights Issue Example

Suppose ABC Ltd announces:

• Issue Ratio: 2 shares for every 7 shares held
• Issue Price: ₹85 per share
• Current Market Price: ₹140 per share

If you hold 70 shares on the record date, you may receive 20 REs.

You could then choose to:

• Apply for 20 rights shares at ₹85 each
• Sell the 20 REs in the market during the RE trading period
• Take no action, in which case the REs may expire and become worthless after the applicable deadline

To Sum Up

Rights Entitlements give eligible shareholders an opportunity to participate in a company's rights issue while also providing the flexibility to sell their entitlement in the market during the RE trading window.

However, REs are time-sensitive. **Simply holding or purchasing an RE does not automatically give you the underlying equity shares.** Investors who want the shares must complete the rights issue application and make the required payment within the prescribed timeline.

For Sunrest Lifescience Limited, the Rights Issue is open from **August 18 to September 2, 2026**, at an issue price of **₹35 per share** and an entitlement ratio of **1:1**. Meanwhile, **SUN-RE will trade only until August 28, 2026**, with RE trading scheduled to be suspended from **August 31, 2026**.

Investors holding or buying SUN-RE should therefore keep both deadlines in mind—the **RE trading deadline of August 28** and the **Rights Issue closing date of September 2**—to avoid allowing their entitlements to lapse unintentionally.

For a detailed explanation of how rights issues work, eligibility criteria, Rights Entitlements (REs), and the application process, read our [Complete Guide to Rights Issues](https://www.arihantplus.com/blogs/investing/rights-entitlement-simplified-for-investors).